Intranasal Delivery of Topically-Acting Levofloxacin to Rats: a Proof-of-Concept Pharmacokinetic Study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmaceutical Research

• Publication date

  2017-07-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-017-2232-1PMID 28748398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.

  2017cited by this paper
• Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease

  2017cited by this paper
• Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate

  2016cited by this paper
• Medical management of chronic rhinosinusitis – an update

  2016cited by this paper
• Clinical Practice Guideline (Update)

  2015cited by this paper
• Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits

  2015cited by this paper
• Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis

  2015cited by this paper
• Topical and Intravenous Antibiotics

  2015cited by this paper
• Practical Medical and Surgical Management of Chronic Rhinosinusitis

  2015cited by this paper
• Clinical Practice Guideline (Update): Adult Sinusitis

  2015cited by this paper
• Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route

  2014cited by this paper
• Role of Pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin

  2014cited by this paper
• Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles.

  2014cited by this paper
• Thermoreversible Nasal In situ Gel of Venlafaxine Hydrochloride: Formulation, Characterization, and Pharmacodynamic Evaluation

  2013cited by this paper
• Update on the management of chronic rhinosinusitis

  2013cited by this paper
• Mucoadhesive in situ gels as nasal drug delivery systems: an overview

  2012cited by this paper
• Thermoreversible In-Situ Ophthalmic Gelling System of Levofloxacin Hemihydrate: Formulation and Optimization by Factorial Design

  2012cited by this paper
• EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

  2012cited by this paper
• Levofloxacin

  2012cited by this paper
• Novel Mucoadhesive Polymers for Nasal Drug Delivery

  2012cited by this paper
• Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

  2012cited by this paper
• Levofloxacin

  2012cited by this paper
• Treatment options for chronic rhinosinusitis.

  2011cited by this paper
• Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma.

  2011cited by this paper
• Some ethical aspects of xenotransplantation in light of the proposed European directive on the protection of animals used for scientific purposes.

  2010cited by this paper
• Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.

  2009cited by this paper
• Biofilms in Chronic Rhinosinusitis: A Review

  2009cited by this paper
• Disposition of Drugs in Block Copolymer Micelle Delivery Systems

  2008cited by this paper
• Prevalence of Biofilm-forming Bacteria in Chronic Rhinosinusitis

  2008cited by this paper
• Topical Antimicrobials in the Management of Chronic Rhinosinusitis: A Systematic Review

  2008cited by this paper
• Treatment alternatives for chronic rhinosinusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail.

  2008cited by this paper
• Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose.

  2007cited by this paper
• Evidence-Based Recommendations for Antimicrobial Nasal Washes in Chronic Rhinosinusitis

  2006cited by this paper
• The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium

  2006cited by this paper
• Biofilm Formation by Staphylococcus Aureus and Pseudomonas Aeruginosa is Associated with an Unfavorable Evolution after Surgery for Chronic Sinusitis and Nasal Polyposis

  2006cited by this paper
• Thermoreversible-mucoadhesive Gel for nasal delivery of sumatriptan

  2006cited by this paper
• Model of Disposition of Drugs Administered into the Human Nasal Cavity

  2004cited by this paper
• Development of the quinolones.

  2003cited by this paper
• Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

  2003cited by this paper
• Nebulized Antibiotics for the Treatment of Acute Exacerbations of Chronic Rhinosinusitis

  2002cited by this paper
• A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus.

  2002cited by this paper
• A critical review of the fluoroquinolones: focus on respiratory infections.

  2002cited by this paper
• Use of Nebulized Antibiotics for Acute Infections in Chronic Sinusitis

  2002cited by this paper
• A Critical Review of the Fluoroquinolones

  2002cited by this paper
• Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels.

  2001cited by this paper
• Physicochemical aspects of drug delivery and release from polymer-based colloids

  2000cited by this paper
• The Clinical Pharmacokinetics of Levofloxacin

  1997cited by this paper
• Local Absorption Kinetics of Levofloxacin from Intestinal Tract into Portal Vein in Conscious Rat Using Portal-Venous Concentration Difference

  1996cited by this paper
• The nasal mucociliary apparatus. Correlation of structure and function in the rat.

  1984cited by this paper
• Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns.

  1972cited by this paper

• Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions

  2024cites this paper
• Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

  2024cites this paper
• Arginine-Rich Cell-Penetrating Peptide-Mediated Transduction of Mouse Nasal Cells with FOXP3 Protein Alleviates Allergic Rhinitis

  2023cites this paper
• Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts

  2022cites this paper
• Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration

  2020cites this paper
• Intranasal Drug Delivery into Mouse Nasal Mucosa and Brain Utilizing Arginine-Rich Cell-Penetrating Peptide-Mediated Protein Transduction

  2019cites this paper